MusclePharm, which makes brand-name sports activities diet merchandise and vitality drinks, filed an software Friday with the SEC to lift as much as $10 million in an preliminary public providing. The corporate is at present listed on the OTC (MSLP) with a market capitalization of roughly $6 million.
If the corporate’s market capitalization is lower than $50 million on the time of its value and replace, MusclePharm might be excluded from Renaissance Capital’s 2022 IPO statistics.
MusclePharm develops, manufactures, markets and distributes brand-name sports activities diet merchandise and practical vitality drinks. The corporate’s portfolio consists of six merchandise underneath the MusclePharm and FitMiss manufacturers, that are offered in additional than 100 international locations worldwide by means of its lately launched specialty, worldwide, FDM and grocery and comfort distribution channels.
The Las Vegas, NV-based firm was based in 2006 and posted $50 million in gross sales in the course of the 12 months ending March 31, 2022. It plans to commerce on Nasdaq underneath the image MSLP. Roth Capital is the only real bookrunner for the deal. Pricing phrases weren’t disclosed.
